Notify me when Tyndall Capital Partners L P files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics, Inc. | Common Stock, no par value | 4.8% | $487K | -$30.1K | 155K | -5.82% | Tyndall Capital Partners, L.P. | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|